{"id":1977,"name":"VenBio Partners","slug":"venbio-partners","website":"https://www.venbio.com","hqGeo":"San Francisco, CA","stageFocus":["Pre-Seed","Growth"],"sectorTags":["Healthcare"],"excludedSectors":[],"checkSizeMin":2000000,"checkSizeMax":5000000,"thesisSummary":"venBio invests in life sciences and biotech companies that focus on transformative therapies addressing large unmet medical needs.","thesisNarrative":null,"logoUrl":null,"aumUsd":2000000000,"submissionUrl":null,"linkedinUrl":null,"twitterHandle":null,"portfolio":[{"companyName":"Alector","companyUrl":null,"stage":null,"sector":"Biotech","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Apellis Pharmaceuticals","companyUrl":null,"stage":null,"sector":"Pharmaceuticals","investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Candid Therapeutics","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Vicebio","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Pharvaris","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by GSK","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Bristol Myers Squibb","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Alumis","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: ACHV","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: AKRO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Novo Nordisk","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: ALMS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: ALXO","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: APLS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Biogen","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Johnson & Johnson","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: ARTV","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Bayer","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: AUPH","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by UCB","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: CMPI","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Regeneron","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"CINC","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by AstraZeneca","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: HRMY","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Lyell Immunopharma Inc","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: IMPL","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Teva Pharmaceuticals","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: LYEL","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: PBLS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: PHVS","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: DTIL","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: RYZB","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Genentech/Roche","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: TPTX","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Eli Lilly and Company","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: VRNA","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Merck","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"ACQ by Sanofi","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"NASDAQ: VTYX","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":null,"amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"venBio Global Strategic Fund III, L.P.  (CIK 0001739920)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning VenBio Partners","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"venBio Global Strategic Fund V, L.P.  (CIK 0002029777)","companyUrl":null,"stage":null,"sector":null,"investmentYear":null,"description":"SEC Form D filing mentioning VenBio Partners","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Achieve Life Sciences","companyUrl":null,"stage":"private placement / late-stage financing","sector":"biopharma","investmentYear":null,"description":"Late-stage specialty pharmaceutical company developing cytisinicline for nicotine dependence","amountUsd":null,"relevanceNote":null,"fundName":null},{"companyName":"Oak Hill Bio","companyUrl":null,"stage":"Series A","sector":"biopharma","investmentYear":null,"description":"Biotechnology company advancing antisense oligonucleotide therapy Rugonersen into Phase 3 for Angelman syndrome","amountUsd":null,"relevanceNote":null,"fundName":null}],"partnerCount":4,"partners":[{"id":8959,"name":"Corey Goodman","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/corey-goodman-5831b1133","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8960,"name":"Richard Gaster","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/richard-gaster-m-d-ph-d-44372815","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":8958,"name":"Aaron Royston","title":"Managing Partner","seniority":null,"focusTags":[],"linkedinUrl":"https://www.linkedin.com/in/aaron-royston-6a1a1b13","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]},{"id":2103,"name":"Robert Adelman","title":"Managing Partner","seniority":null,"focusTags":["Biotech","Pharmaceuticals"],"linkedinUrl":"https://www.linkedin.com/in/robert-adelman-1b1b2b7","twitterHandle":null,"blogUrl":null,"thesisSummary":null,"whyThisPartner":null,"recentPosts":[]}],"funds":[],"activity":{"lastInvestmentYear":null,"investmentsThisYear":0},"activityItems":[{"kind":"news","title":"Oak Hill Bio Raises $32.5 Million Series A Financing to Advance Antisense Oligonucleotide Therapy Rugonersen to Phase 3 Study in Angelman Syndrome","url":"https://www.venbio.com/2026/06/01/","source":"venBio","occurredAt":"2026-06-01T00:00:00.000Z"},{"kind":"news","title":"Achieve Life Sciences Announces Up to $354 Million Private Placement","url":"https://www.venbio.com/2026/04/16/","source":"venBio","occurredAt":"2026-04-16T00:00:00.000Z"},{"kind":"news","title":"venBio Raises $528 Million Venture Capital Fund Focused on Life Science Companies","url":"https://www.venbio.com/venbio-raises-528-million-venture-capital-fund-focused-on-life-sciencecompanies/","source":"venBio","occurredAt":"2026-01-12T00:00:00.000Z"}],"contentUpdatedAt":"2026-11-12T03:21:16.672Z","investorType":"vc","preferredApproach":"warm intro preferred","prefersFounderType":null,"oneClickPitchEnabled":false,"relatedFirms":[{"id":11323,"name":"Mountain Pine Capital","slug":"mountain-pine-capital","logoUrl":null,"website":"https://mountainpineholdings.com/","stageFocus":["Seed"],"sectorTags":["Consumer","Healthcare","Real Estate"],"hqGeo":"Salt Lake City, UT"},{"id":12955,"name":"Jovono","slug":"jovono","logoUrl":null,"website":"https://jovono.com","stageFocus":["Seed","Series A"],"sectorTags":["Climate / Energy","Fintech","Consumer","SaaS","Healthcare"],"hqGeo":"Los Angeles, CA"},{"id":12160,"name":"Solid Ventures","slug":"solid-ventures","logoUrl":null,"website":"https://www.solidventures.vc/","stageFocus":["Seed"],"sectorTags":["Fintech","Healthcare","SaaS","Enterprise","Developer Tools","Consumer"],"hqGeo":"Austin, TX"},{"id":13026,"name":"Robin Capital","slug":"robin-capital","logoUrl":null,"website":"https://robincap.com/","stageFocus":["Pre-Seed","Seed"],"sectorTags":["AI / ML","Fintech","SaaS","Climate / Energy","Healthcare"],"hqGeo":"Berlin, Germany"},{"id":12096,"name":"TeleHealth Ventures","slug":"telehealth-ventures","logoUrl":null,"website":"https://telehealthventures.com","stageFocus":["Seed"],"sectorTags":["Healthcare"],"hqGeo":"Austin, TX"},{"id":2457,"name":"Equilibrium Ventures","slug":"equilibrium-ventures","logoUrl":null,"website":"https://equilibrium.co/","stageFocus":["Seed"],"sectorTags":["Developer Tools","Healthcare"],"hqGeo":"Portland, OR"}],"featuredIn":[{"slug":"healthcare","displayName":"Healthcare Investors","pageType":"industry"}],"fundraisingResources":[{"slug":"how-many-investors-should-you-pitch","title":"How Many Investors Should You Pitch? The Math Most Founders Get Wrong"},{"slug":"what-vcs-actually-look-for-pitch-deck","title":"What VCs Actually Look for in a Pitch Deck"},{"slug":"find-right-pre-seed-investors-b2b-saas","title":"How to Find the Right Pre-Seed Investors for Your B2B SaaS Startup"}],"overviewNarrative":"VenBio Partners is a venture capital firm headquartered in San Francisco, California. The firm invests in life sciences and biotech companies that focus on transformative therapies addressing large unmet medical needs.\n\nVenBio Partners participates in early and growth stage investments within the healthcare and pharmaceuticals sectors, with a particular interest in pain management. Typical check sizes range from $2.0 million to $5.0 million. The firm has assets under management of $2 billion and prefers to be approached via warm introduction.","portfolioNarrative":"VenBio Partners has recorded investments in 44 portfolio companies. The firm has participated in financings for Achieve Life Sciences in the biopharma sector as well as multiple acquisitions by major pharmaceutical companies including Alumis, AstraZeneca, Bayer, Biogen, Bristol Myers Squibb, Eli Lilly and Company, Genentech/Roche, GSK, Johnson & Johnson, Lyell Immunopharma Inc, Merck, Novo Nordisk, Regeneron, and Sanofi.\n\nThese recorded investments reflect the firm's focus on healthcare, pharmaceuticals, and pain management across early and growth stages.","seoTitle":null,"seoDescription":null,"lastVerifiedAt":"2026-06-06T09:22:07.375Z"}